Did the FDA miss the potential harm... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 23, 2026 Read More
Food and Drug Administration issues recall of... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 27, 2026 Read More
FDA says an OTC heartburn medication could... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
An FDA Class I recall means the... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 27, 2026 Read More
Food and Drug Administration drug recall classifications By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Food and Drug Administration says micro-bacteria found... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 27, 2026 Read More
Food and Drug Administration asks for breast... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
FDA announces OTC eye product recall By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Should you always take what your doctor... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
FDA receives reports of yet another carcinogen... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 23, 2026 Read More
Food and Drug Administration under scrutiny re... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 21, 2026 Read More
What patients should know about all these... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More